ASN-51
- Generic Name
- ASN-51
Study of ASN51 in Adults With Early Alzheimer's Disease
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Asceneuron S.A.
- Target Recruit Count
- 123
- Registration Number
- NCT06677203
- Locations
- 🇺🇸
K2 Medical Research, Maitland, Florida, United States
🇺🇸K2 Medical Research - The Villages, Lady Lake, Florida, United States
🇺🇸Alzheimer's Treatment and Research Center, Wellington, Florida, United States
Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Asceneuron S.A.
- Target Recruit Count
- 3
- Registration Number
- NCT06390098
- Locations
- 🇬🇧
Hammersmith, London, United Kingdom
Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects
Phase 1
Completed
- Conditions
- Drug Drug Interaction
- Interventions
- First Posted Date
- 2024-01-30
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Asceneuron S.A.
- Target Recruit Count
- 50
- Registration Number
- NCT06232109
- Locations
- 🇳🇱
ICON Groningen Van Swietenlaan 6, Groningen, Netherlands
PET Study of Repeated ASN51 in Healthy Volunteers
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Asceneuron S.A.
- Target Recruit Count
- 12
- Registration Number
- NCT05725005
- Locations
- 🇬🇧
Hammersmith, London, United Kingdom
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Asceneuron Pty Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT04759365
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath